危急疾病:胆固醇和血管活性药物的联合作用:试点研究
Rodopi Stamatiou1, Anna Vasilaki2, Dimitra Tzini2
1Physiology Laboratory, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece.
Antibiotics (Basel, Switzerland)
|June 28, 2023
概括
胆固醇可以导致肌肉损伤 (肌肉病变) 在危急病患者. 然而,血管收缩药物可能会减少这种由胆固醇诱导的肌肉病变,特别是在败血症状态下,这表明需要仔细监测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 密集护理医学 密集护理医学
背景情况:
- 胆固醇是一种针对多药耐药性感染的最后手段抗生素.
- 胆固醇诱导的肌肉病变是重症监护室的一个重大问题.
- 血管收缩药物用于控制重症患者的血压和器官 perfusion.
研究的目的:
- 为了研究胆固醇诱导的肌肉毒性的机制.
- 评估血管收缩剂对胆固醇诱导肌肉病的作用.
- 为了确定败血症对胆固醇肌肉毒性的影响.
主要方法:
- 单独或与血管收缩剂一起给非败血症和败血症动物模型10天使用胆固醇素.
- 胃角肌肉的组织病理学检查.
- 对蛋白质水平进行点点分析 (AMPK,cyclin-D1,caspase3).
主要成果:
- 胆固醇诱导肌肉病变,其特征是肌内面积增加和肌肉纤维混乱.
- 血管收缩药物改善了胆固醇诱导的肌肉病变.
- 在败血症动物中,胆固醇降低了AMPK和环素-D1水平,血管缩剂可以逆转这些影响.
结论:
- 胆固醇的肌肉毒性受血管收缩的存在和动物的败血症状态的影响.
- 血管收缩药物可以减轻胆固醇诱导的肌肉病变.
- 这些发现强调了在重症监护室中给予胆固醇素时考虑患者状况的重要性.
相关概念视频
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
14
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
14
Combined Effects of Drugs: Antagonism
8.7K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.7K
Pneumonia III: Complications and Assessment
278
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
278
Chronic Pancreatitis II: Collaborative Care
116
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
116


